Combination Products: Everyone Wants to Be a Device
This article was originally published in RPM Report
Executive Summary
Part of the fun of having a combination product is requesting a designation for your product to see what center will review it. Not surprisingly, most companies hope for CDRH.
You may also be interested in...
FDA Under Pressure On Its Approach To Assigning Combo Product Jurisdiction
A federal court handed down a potentially significant ruling related to FDA’s policies for designating primary product review responsibility to the drug, biologic or device center just days after members of Congress questioned FDA on its approach.
Drug Shortage Could Be Addressed By ‘Resilience Rating’ From Private Entity Under HHS Plan
US HHS is proposing a public-private partnership to assign ratings to manufacturers based on quality/resilience of supply, tied to a purchasing incentive program for providers. The non-agency approach may be key to overcoming industry and political objections.
Drug Shortage Could Be Addressed By ‘Resilience Rating’ From Private Entity Under HHS Plan
US HHS is proposing a public-private partnership to assign ratings to manufacturers based on quality/resilience of supply, tied to a purchasing incentive program for providers. The non-agency approach may be key to overcoming industry and political objections.